Dr. Dean Louis Fanelli

Dean advises chemical, pharmaceutical and biotechnology companies on patent portfolio creation and management, counseling, technology transactions, due diligence, and opinion work, including drafting novelty, freedom-to-operate and invalidity opinions. He regularly handles IP issues relating to mergers and acquisitions, including corporate governance and setup, drafting and negotiating asset purchase agreements, licensing agreements, shareholder rights agreements and financing for life sciences companies. Dean also has experience in patent litigation under the Hatch-Waxman Act, developing Paragraph IV litigation strategies as well as biosimilar market and patent assessments.